- Home
- CNTA vs FULT Comparison
CNTA vs FULT Comparison
Compare CNTA & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | FULT |
|---|---|---|
| Founded | 2020 | 1882 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTA | FULT |
|---|---|---|
| Price | $27.73 | $19.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | ★ $40.89 | $21.40 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.81% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.75 |
| Revenue Next Year | N/A | $5.56 |
| P/E Ratio | ★ N/A | $10.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.60 | $14.33 |
| 52 Week High | $30.58 | $22.99 |
Technical Indicators
Market Signals| Indicator | CNTA | FULT |
|---|---|---|
| Relative Strength Index (RSI) | 62.51 | 36.17 |
| Support Level | $21.93 | $19.15 |
| Resistance Level | $30.29 | $19.97 |
| Average True Range (ATR) | 1.18 | 0.65 |
| MACD | 0.14 | -0.21 |
| Stochastic Oscillator | 72.50 | 12.54 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.